<p>* The patient who was lost to follow-up at 3 months was excluded from the analysis of the 3 month results. ** For the patients who were lost to follow-up at 6 months, the 3-month data were carried forward in the analysis of the 6-month results.</p
1<p>Includes cases lost to follow-up within five years of diagnosis.</p>2<p>Excludes cases lost to f...
*1 patient withdrew; 5 patients did not meet continuation criteria. †1 patient within this group was...
Events represent number of patients who were were lost-to-follow-up and died at the end of the study...
<div><p>This figure describes the state of the trial corresponding to planned visits up to 30 April ...
Events represent number of patients who were were lost-to-follow-up (neither retained nor died) at t...
<p>Progression of participants in the trial, including those who met the exclusion criteria, those w...
<p>*28 patients were lost to follow up at six months.</p><p>Results of post-procedural occlusion and...
Treatment effects are often evaluated by comparing change over time in outcome measures. However, va...
Loss to follow-up indicates both patients not reporting and inability to trace them during the requi...
<p>a: data from the closest previous timpoint for VL, CD4, CD8. The gap was 14–35 days.</p><p>b: not...
<p><sup>1</sup>Only data that accrued until the study participant was prematurely withdrawn from the...
<p>*imputed data for 1 patient in Text group (11 v 10 observed) and 3 in the No text group (22 v 19 ...
<p>Proportion of patients lost to follow-up at 12 months: comparison of estimates according to the s...
<p>Percentage figures do not sum to 100 because it was also possible for the hospital to cancel an a...
<p>In Analysis 1, patients were followed for 365 days for the outcomes of interest. In Analysis 2, a...
1<p>Includes cases lost to follow-up within five years of diagnosis.</p>2<p>Excludes cases lost to f...
*1 patient withdrew; 5 patients did not meet continuation criteria. †1 patient within this group was...
Events represent number of patients who were were lost-to-follow-up and died at the end of the study...
<div><p>This figure describes the state of the trial corresponding to planned visits up to 30 April ...
Events represent number of patients who were were lost-to-follow-up (neither retained nor died) at t...
<p>Progression of participants in the trial, including those who met the exclusion criteria, those w...
<p>*28 patients were lost to follow up at six months.</p><p>Results of post-procedural occlusion and...
Treatment effects are often evaluated by comparing change over time in outcome measures. However, va...
Loss to follow-up indicates both patients not reporting and inability to trace them during the requi...
<p>a: data from the closest previous timpoint for VL, CD4, CD8. The gap was 14–35 days.</p><p>b: not...
<p><sup>1</sup>Only data that accrued until the study participant was prematurely withdrawn from the...
<p>*imputed data for 1 patient in Text group (11 v 10 observed) and 3 in the No text group (22 v 19 ...
<p>Proportion of patients lost to follow-up at 12 months: comparison of estimates according to the s...
<p>Percentage figures do not sum to 100 because it was also possible for the hospital to cancel an a...
<p>In Analysis 1, patients were followed for 365 days for the outcomes of interest. In Analysis 2, a...
1<p>Includes cases lost to follow-up within five years of diagnosis.</p>2<p>Excludes cases lost to f...
*1 patient withdrew; 5 patients did not meet continuation criteria. †1 patient within this group was...
Events represent number of patients who were were lost-to-follow-up and died at the end of the study...